Epic Research

Monday, December 10, 2012

Epic Update : Ind-Swift Laboratories

Ind-Swift Laboratories is targeting to garner revenues of Rs 1,500 crore by 2015. For achieving the same, the company will continue to focus on its active pharmaceuticals Ingredients (API) business in European Union, Japan, Australia and US which will be the main drivers of growth for future. At present, the company’s revenues stand at over Rs 1,000 crore.
Get Free MCX TipsStock TipsForex Tips & NCDEX Tips,Commodity TipsShare Tipscommodity tips free trialnifty free tipscommodity trading tipsshares tipsShare Market TipsStock Market Tipsfree stock tips on mobileStock trading tipsIntraday Tips.

No comments:

Post a Comment